Latest News and Press Releases
Want to stay updated on the latest news?
-
4. november, 2025Meddelelse nr. 23 Opdatering af forretningsstrategi – Strategien "Forward", aspirationer frem mod 2028 og finansieringsbehov KØBENHAVN, DANMARK, 4. november, 2025, (GLOBE NEWSWIRE)...
-
November 4, 2025Announcement no. 23 Business Strategy Update – the “Forward” Strategic Direction, Aspirations towards 2028 and Funding Needs Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) –...
-
4. november, 2025 Meddelelse nr. 22 Forudgående offentliggørelse af de finansielle nøgletal for 3. kvartal 2025 og reviderede forventninger til...
-
November 4, 2025 Announcement no. 22 Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025 Copenhagen,...
-
4. november, 2025Meddelelse nr. 21 Statusopdatering på BioPortos kliniske studie for voksne KØBENHAVN, DANMARK, 4. november – BioPorto A/S (BioPorto eller Selskabet) (CPH:BIOPOR), annoncerede i...
-
November 4, 2025Announcement no. 21 Progress Update on BioPorto’s Adult Clinical Study Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”)...
-
26. september, 2025Meddelelse BioPorto sponsorerer konferencer om pædiatrisk intensiv behandling med præsentation af nye videnskabelige data om NGAL KØBENHAVN, DANMARK og BOSTON, MA, USA, 26....
-
September 26, 2025News Release BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented COPENHAGEN, DENMARK and BOSTON, MA, USA, September 26 – BioPorto A/S...
-
11. september, 2025Meddelelse US News & World Report-webinaret “New Frontiers in Kidney Care” fremhæver NGAL-biomarkøren KØBENHAVN, DANMARK og BOSTON, MA, USA, 11. september – BioPorto A/S...
-
September 11, 2025News Release US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker COPENHAGEN, DENMARK and BOSTON, MA, USA, September 11 – BioPorto A/S...